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SplicingRecombinant glycoproteins can be produced at high levels in permanently transfected mammalian cells
using expression vectors with strong viral promoters. CHO-K1 cell lines developed to produce the recom-
binant complement activator blocking protein, CAB-2 (a fusion of membrane co-factor protein, MCP, and
decay accelerating factor, DAF), showed unexpectedly low expression. Northern blot analysis revealed
that in addition to the expected 2300 base CAB-2 mRNA species, these cell lines expressed 790 and
1500 base mRNA species accounting for 50% and 10% of the total CAB-2 mRNA, respectively. RT-
PCR studies established that the 1500 base species resulted from aberrant splicing from within the
DAF region of the CAB-2 coding sequence to a site within the 30 untranslated region. 30 RACE analysis con-
ﬁrmed that the 790 base species resulted from premature polyadenylation at an AATAAA site within the
MCP coding region of CAB-2. Another prematurely polyadenylated species, not observed on Northern
blots, was observed in the DAF region by 30 RACE. Analysis of human tissues and cell lines revealed that
these internal polyadenylation signals in native MCP and DAF coding regions also generated prematurely
polyadenylated mRNAs. Genetic modiﬁcation of these functional RNA processing elements within the
CAB-2 gene eliminated the aberrant mRNA species and signiﬁcantly increased recombinant CAB-2
expression. These results illustrate that protein expression can be limited by aberrant mRNA processing
and demonstrate the importance of identifying and eliminating these mRNA processing signals from
within coding DNA to maximize recombinant protein expression.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license.Introduction
A common strategy employed within the biotechnology indus-
try is to develop expression systems containing genetic elements
proven to yield high – level productivity and to employ these sys-
tems for production of numerous products. Productivity, however,
can vary from protein to protein, often leading to signiﬁcant devel-
opment challenges for poorly-expressed proteins. In some cases,
the cause of poor expression has been determined [1,2], while in
others, the causes remain unresolved [3,4].
We have utilized a CHO-K1 production system in conjunction
with a sequential transfection strategy using expression vectors
containing the CMV promoter and the neo gene encoding G418
resistance for the ﬁrst transfection and the hisD gene encoding his-
tidinol resistance for the second transfection to stably express thesoluble chimeric complement activator blocker protein, CAB-2.
CAB-2 consists of portions of two human regulators of complement
activation (RCAs),1 membrane cofactor protein (MCP) and decay
accelerating factor (DAF) [5]. Native MCP and DAF are both plasma
membrane-associated molecules that contain four short consensus
repeat (SCR) motifs, a Serine–Threonine–Proline (STP) rich region,
a transmembrane domain and a cytoplasmic tail. CAB-2 retains the
signal sequence, 4 SCR units and the ﬁrst 2 amino acids of the STP
region of MCP fused to the 4 SCR units and STP region of DAF
(Fig. 1). CAB-2 possesses in vitro complement inhibition activities
greater than the individual activities of soluble forms of MCP or
DAF alone and acts by blocking both the C3 and C5 convertases
which are essential components of the complement activation path-
way thus preventing complement – mediated tissue damage in vivo
[5,6]. Complement activation is believed to contribute to harmful
inﬂammatory responses which can occur in cardiopulmonary bypass
procedures resulting in signiﬁcant complications [6]. CAB-2 wasembrane
eat; STP,
Primer.
Fig. 1. The CAB-2 transcription unit. The CMV promoter along with a small intron in the 50 untranslated region and mouse immunoglobulin kappa light chain 30 untranslated
region (30 UTR) ﬂank the CAB-2 gene. The CAB-2 coding region includes the MCP signal sequence (SP), Short Consensus Repeats (SCR) segments and the ﬁrst two amino acids
of the Serine–Threonine–Proline rich (STP) region fused to the DAF SCR segments and entire STP region. The cDNA probe used in Northern blotting is represented by a grey
box. The straight arrows represent forward primers (P4, P5, P6, and P7) used in 30 RACE PCR and the bent arrows represent locations of RT-PCR primers (P1, P2 and P3) used to
amplify the cDNAs. The locations of the internal polyadenylation (AATAAA) sequences are shown.
S.D. Wijesuriya et al. / Protein Expression and Puriﬁcation 92 (2013) 14–20 15developed as a therapeutic to reduce the incidence of these compli-
cations by inhibiting complement activation.
In our CHO-K1 production system, sequential transfection to in-
crease gene copy number typically can yield up to a twofold in-
crease in expression from the ﬁrst to second transfection. For
CAB-2, the top-producing G418 – and histidinol – resistant sequen-
tial transfectants expressed only modestly higher levels (20–30%)
than the initial top G418-resistant transfectants. The lower than
expected expression levels suggested that transcriptional, transla-
tional or secretional factors could be limiting protein expression.
To determine if transcriptional factors were a cause for the rela-
tively poor expression, we performed a detailed analysis of CAB-
2 mRNA from CHO-K1 cells transfected with expression vectors
containing CAB-2 cDNA. We found that functional polyadenylation
sequences within the MCP and DAF coding regions of the CAB-2
cDNA as well as aberrant splicing originating from a cryptic splice
donor site within DAF produced truncated RNA species which com-
prised a signiﬁcant proportion of the total CAB-2-speciﬁc mRNA.
We also show that modiﬁcation of the CAB-2 cDNA to eliminate
these signals yielded a more homogeneous full – length mRNA
and substantially increased recombinant protein expression.Materials and methods
Expression vector construction and transfection
The CAB-2 cDNA encoding amino acids 1–288 of MCP (including
the signal sequence and up to the transmembrane domain) and 1–
322 of DAF (excluding the signal sequence and extending to the
transmembrane domain) in tandem was cloned into a mammalian
expression vector containing the CMV promoter and the mouse
immunoglobulin kappa light chain 30 untranslated region along
with selective marker genes encoding resistance to G418 (Geneti-
cin) or histidinol. Linearized vectors were transfected into CHO-
K1 cells by electroporation. Following recovery, transfected cells
were seeded in 96-well plates. Several dilutions of the transfected
cells were seeded so as to ensure a high probability of obtaining
wells with single colonies. Single colonies were conﬁrmed by
microscopic examination.
Cell lines expressing recombinant CAB-2 were developed by ini-
tially transfecting CHO-K1 cells with an expression vector contain-ing the CAB-2 gene and the neo gene encoding resistance to G418
followed by re-transfection of the top expressing G418-resistant
cell lines with a vector containing two copies of the CAB-2 gene
and the selectable marker (hisD) encoding resistance to histidinol.Cell culture
CHO-K1 cells were maintained in EX-CELL 301 medium (SAFC
Biosciences, Lenexa, KS). Transfectants were selected and propa-
gated in Ex-Cell 301 or EX-CELL 302 medium (SAFC Biosciences,
Lenexa, KS) containing 0.8 g/L G418 (Invitrogen, Carlsbad, CA) or
0.4 g/L G418 plus 8 mM histidinol (Sigma Chemicals, St Louis,
MO). Culture supernatants from CAB-2-expressing clones were
evaluated by ELISA at the 96-well and 24-well screening stages.
The top-producing clones derived from single colonies were fur-
ther evaluated in shake ﬂask tests performed in selective agent-
free media at a starting cell density of 2  105 cells/ml. Extinct cul-
ture supernatants were assayed on Day 14 by ELISA.Elisa
ELISA plates were pre-coated with a murine monoclonal IgG1
against MCP. After blocking with PBS containing 1% BSA and 0.5%
TWEEN 20, plates were incubated with cell culture supernatants.
This was followed by a two – step incubation ﬁrst with a polyclonal
rabbit anti-CAB-2 antibody followed by a mouse anti-rabbit anti-
body conjugated to horse radish peroxidase. The plates were devel-
oped using the TMB detection system (KPL, Gaithersburg MD) and
read on a Biotek ELISA plate reader at 450 nm.Northern blotting
Total RNA was isolated from cell lines using TRI-reagent
(Molecular Research, Cincinnati, OH). RNA from CAB-2 – producing
clones (20 lg each) was run on an agarose-formaldehyde gel, blot-
ted and hybridized with a 32P – labeled cDNA probe (Fig. 1) using
the NorthernMax Kit (Ambion Inc, Austin, TX). The integrity and
uniformity of the RNA was conﬁrmed by stripping blots and
re-hybridizing with a probe for glyceraldehyde phosphate
dehydrogenase (GAPDH) as an internal expression control.
Fig. 2. Northern blot of total RNA from CAB-2 – producing transfectants hybridized
with a 531 bp cDNA probe comprising the 50UTR through SCR1 of MCP. Lanes 1–2,
RNA from a CAB-2 – expressing transfectant. Lanes 3–4, RNA from untransfected
CHO-K1 cells. The 2300 bases full – length and 1500 bases and 790 bases CAB-2
transcripts are identiﬁed.
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Total RNA, isolated as described above, was treated with DNase
I to remove any contaminating DNA. Random hexamer (1 lg) and
oligo dT (0.5 lg) primers were used for ﬁrst-strand cDNA synthesis
using SuperScript II reverse transcriptase (Invitrogen Corp, Carls-
bad, CA) and 2 lg of each DNase–I – treated RNA. PCR was per-
formed using 2 lg of ﬁrst-strand cDNA and primers (P1, P2 and
P3) in the 50 and 30 untranslated regions ﬂanking the CAB-2 cDNA
(see Fig. 1).
30 RACE
30 RACE was performed using a 30 RACE kit (Invitrogen Corp,
Carlsbad, CA). Total RNA isolated from CAB-2 – transfected cells,
cell lines and various tissues was reverse-transcribed into cDNA
using the Adapter (AP) primer. PCR was performed using the
Abridged Universal Adapter Primer (AUAP) and gene-speciﬁc for-
ward primers (P4, P5, P6 and P7) located within MCP and DAF
(see Fig. 1) to amplify any prematurely polyadenylated transcripts.
The resulting PCR products were veriﬁed by DNA sequence
analysis.
Site-directed mutagenesis
Changes in the CAB-2 gene to correct the two functional, inter-
nal AATAAA sites and the splice donor site were made using in-
verse PCR and DpnI digestion [7]. Complementary primers
overlapping the site of change were used to PCR amplify the whole
plasmid in a mixture containing 500 mM dNTPs, 2 units of Pfu
polymerase, 250 ng each of sense and antisense primers and
200 ng of CAB-2 plasmid DNA. PCR involved 18 cycles with an
extention time of 2.5 min for each Kb of DNA. PCR products were
treated with Dpn1 (which only digests the adenine-methylated
plasmid DNA) and transformed into Escherichia coli DH5a cells.
Transformants were evaluated by restriction enzyme digestion
for incorporation of the changes and conﬁrmed by DNA sequence
analysis.Results
To maximize CAB-2 expression, CHO-K1 cells ﬁrst were trans-
fected with a vector containing the CAB-2 gene and the neo gene
encoding resistance to G418. The top G418-resistant CAB-2 pro-
ducing clones then were re-transfected with a vector containing
the CAB-2 gene and the hisD gene encoding resistance to histidinol.
Increasing gene copy number by performing a sequential transfec-
tion typically can yield up to a two-fold increase in expression
from the ﬁrst to second transfection. However, following the sec-
ond transfection, the top G418- and histidinol-resistant CAB-2 pro-
ducing clones expressed only 20–30% higher levels than the G418
resistant clones (results not shown).
To understand the cause for the lower than expected expression
levels, CAB-2-speciﬁc mRNA, isolated from CHO-K1 transfectants,
was analyzed by Northern blot using a cDNA probe encoding the
50 untranslated region through SCR1 of MCP (see Fig. 1). In addition
to the expected full length RNA of 2300 bases, two other RNA
species of 1500 and 790 bases were detected (Fig. 2). The
790 base RNA accounted for approximately 50% of total CAB-2
mRNA (estimated by intensity of the band), while the 1500 base
RNA accounted for approximately 10%.
Inspection of the CAB-2 coding sequence revealed three copies
of the polyadenylation signal, AATAAA (see Fig. 1). One of these
sites lies within MCP, 790 bp downstream of the transcription start
site encoding amino acids 167–169. The other two sites are withinDAF, 1811 bp (encoding amino acids 508–509) and 2087 bp
(encoding amino acids 600–601) downstream of the CAB-2 tran-
scription start site, respectively. 30 RACE using primer P4, located
522 bp upstream of the AATAAA sequence within MCP (see
Fig. 1), revealed a 540 bp PCR product in all CAB-2 – producing
transfectants which would result from polyadenylation at the AA-
TAAA site in MCP (Fig. 3A). DNA sequence analysis of this PCR
product revealed that it terminates shortly after the internal MCP
AATAAA sequence. Polyadenylation at this site would account for
the abundant 790 base transcript observed by Northern blot
analysis (see Fig. 2). The distances between the premature polyA
signal identiﬁed in MCP and the ﬁrst and second premature polyA
signals identiﬁed in DAF and the native poly A signal are 1000,
1300, and 1600 base pairs, respectively. The short PCR extension
time used for ampliﬁcation to the MCP poly site would not be ex-
pected to amplify the larger products terminated at the DAF or na-
tive poly A sites. 30 RACE using primer P5, located 342 bp upstream
of the AATAAA site in DAF SCR4, should capture RNA polyadeny-
lated at the two internal DAF AATAAA sites and at the AATAAA site
in the 30 UTR of the vector. The results (Fig. 3B) demonstrated that
only the AATAAA sequence located in DAF SCR4 was used, resulting
in a truncated  380 bp PCR product. As expected, polyadenylation
at the AATAAA site in the 30 UTR yielded a 890 bp PCR product.
These results were conﬁrmed by DNA sequence analysis. It should
be noted that the aberrantly spliced mRNA (described below)
would not be detected in Fig. 3B since the forward primer, P5
(see Fig. 1), is downstream of the splice donor site.
We next investigated whether premature polyadenylation was
unique to the chimeric CAB-2 protein or whether it also occurs in
tissues and cells that express native MCP and DAF proteins. 30 RACE
using primer P6 located in the MCP signal sequence identiﬁed
products of a size indicating use of the MCP internal AATAAA site
in salivary gland, peripheral blood leukocytes (PBL), placenta and
the human T-cell line, HSB2, (Fig. 3C). DNA sequence analysis of
the PCR products from the placenta and HSB2 cells conﬁrmed them
to be products from prematurely – truncated MCP mRNA. Simi-
larly, using primer P7, 30 RACE PCR products of a size (340 bp)
suggesting use of the internal AATAAA site in DAF SCR4 were
faintly observed in the salivary gland and PBL (Fig. 3D). DNA se-
quence analysis conﬁrmed that only the PCR product from the sal-
ivary gland resulted from prematurely polyadenylated mRNA. PCR
products (800 bp) corresponding to correct polyadenylation at
the AATAAA site in the 30UTR for the DAF gene also were observed
in both tissues (Fig. 3D).
RT-PCR was used to identify the source of the 1500 base RNA
species observed by Northern blot analysis. Primers P1 and P2
Fig. 3. RNA analysis of CAB-2 – producing CHO-K1 transfectants and human tissues and cells expressing native MCP and DAF proteins. M, DNA size marker (in all gels). (A) 30
RACE PCR products using primer P4 within MCP and a poly(A)-speciﬁc 30 primer. Lanes 1–6, duplicate cDNAs from three independent CAB-2 transfectants. Lanes 7–8,
untransfected CHO-K1 cDNA, Lanes 9–10, no RNA control. Arrow identiﬁes a 540 bp product resulting from premature polyadenylation. (B) 30 RACE PCR products using
primer P5 within DAF and a poly(A) – speciﬁc 30primer. Lane 1, a CAB-2 – expressing transfectant, lane 2, no RNA control. Arrows identify the 890 bp product resulting from
the expected polyadenylation in the 30UTR and the 380 bp product resulting from premature polyadenylation. (C) PCR products from 30 RACE in human tissues and cells
expressing MCP using primer P6 and a poly(A) – speciﬁc 30 primer. Arrow identiﬁes a 380 bp product resulting from premature polyadenylation. (D) PCR products from 30
RACE in human tissues and cells expressing DAF using primer P7 and a poly(A) – speciﬁc primer. Arrows identify the 800 bp product resulting from polyadenylation in the
native 30UTR and a 340 bp product from premature polyadenylation. PBL, peripheral blood leucocytes, HSB2, T cell line.
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tion unit) ampliﬁed an expected cDNA of 2000 base pairs from
the full length 2300 base mRNA (Fig. 4A, panel a). However, when
reverse primer P3, which lies further downstream in the 30UTR of
the vector, was used in combination with P1, a predominant prod-
uct of 1500 bases was observed (Fig. 4A, panel b). DNA sequencing
conﬁrmed that this product resulted from aberrant splicing from a
non-canonical donor site in SCR2 of DAF to an acceptor site in the
30UTR of the vector (Fig. 4B). No such aberrant splicing was de-
tected in RNA isolated from any natural source expressing DAF
(data not shown), suggesting that this process is unique to the
CAB-2 fusion protein expressed using our expression vector system
in CHO-K1 cells.
To eliminate the truncated mRNA species, the two functional
internal poly(A) sequences and the non – canonical splice donor
sequence were modiﬁed by replacing two nucleotides at each site
without changing the native protein coding sequence. The func-
tional MCP and DAF AATAAA sites were changed to AAGATC and
AACAAG, respectively. The splice donor site encoding amino acids
390–391 was changed from GAACCT to GAGCCC. To evaluate the
beneﬁt of these modiﬁcations, plasmids with changes at each indi-
vidual site and at multiple sites were transiently expressed in CHO-
K1 cells. Analysis of RNA isolated from the transient transfectants
conﬁrmed that these modiﬁcations eliminated the aberrant RNA
species (data not shown). To determine whether these changes im-
proved protein expression levels, CHO-K1 cells were stably trans-
fected with an expression vector containing the CAB-2 cDNAmodiﬁed at all three sites. Expression levels were compared in
pools of transfectants developed using the unmodiﬁed and modi-
ﬁed CAB-2 plasmids. ELISA results of culture supernatants from ex-
tinct pools revealed that those from transfectants generated using
the modiﬁed vector contained, on average, 5-fold higher CAB-2 ti-
ters than those from transfectants generated with the unmodiﬁed
vector (Fig. 5A). Stable clones subsequently were generated by
transfection with the modiﬁed vector followed by limited dilution
cloning. RNA isolated from individual stable clones and analyzed
by 30 RACE (Fig. 5B and C) and RT-PCR (Fig. 5D) conﬁrmed the elim-
ination of the truncated RNA species.Discussion
Sequential transfection of CHO-K1 cells with vectors expressing
recombinant proteins typically yields an increase in expression
that is proportional to gene copy number. However, in the case
of CAB-2, expression increased only modestly following a sequen-
tial transfection. We conclude that this reduced expression was
due primarily to a non-productive truncated RNA species arising
from a polyadenylation signal element within the MCP coding se-
quence and secondarily to an alternatively spliced isoform arising
from a cryptic splice donor site within the DAF coding sequence.
This conclusion is based on the observation that (1) the prema-
turely polyadenylated mRNA comprised the majority of the aber-
rant mRNA species and (2) elimination of these aberrantly
Fig. 4. Analysis of CAB-2 RNA to identify location of splice donor and acceptor sites. Primers are shown in Fig. 1. (A) RNA analysis of CAB-2 – producing transfectants by RT-
PCR of RNA from CAB-2 transfectants. Panel (a) shows the expected full – length 2000 bp PCR products obtained with primer P1 and primer P2. Panel (b) shows aberrantly-
spliced products obtained with primer P1 and primer P3. Lane 1, no DNA control. Lanes 2–3, cDNA from two independent CAB-2 – producing transfectants, Lane 4, plasmid
DNA. M, DNA size marker. The PCR products in Lane 4 (panels a and b) are larger than the cDNA products because they result from ampliﬁcation of the expression plasmid
DNA (which also contains a 50 intron). (B) Schematic representation of aberrant mRNA splicing within CAB-2 mRNA. The spliced sequence, determined by DNA sequence
analysis and shown at the bottom, can result from two possible non-canonical splicing events: (1) fusing the second A of the GAA (CAB-2 codon 390), designated as (a) to the
ﬁrst C of CCT in the 30 untranslated region, designated as (a) or (2) fusing the T of the CCT (CAB-2 codon 391), designated as (b) to the ﬁrst C of the CCC codon in the 30
untranslated region, designated as (b).
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expression.
In a previous study of MCP, Milland et al., [8] found that replac-
ing AT-rich sequences with GC bases, including those within the
same AATAAA sequence we describe, signiﬁcantly increased MCP
expression in both transiently and permanently transfected cells.
They concluded that the reduced expression they observed was
due to translational effects of AU rich mRNA sequences. We cannot
rule out translational effects as an additional cause for our lower
than expected CAB-2 expression since eliminating the internal pol-
yadenylation and cryptic splice donor sequences yielded a 5-fold
increase in expression which was greater than expected as the
amount of full-length CAB-2 mRNA increased from 40% to
100% (2.5-fold). However, since we did not signiﬁcantly reduce
the number of AT base pairs within the MCP region of CAB-2 (only
2 bp were substituted), it is unlikely that the observed expression
improvements are due strictly to reduced AT content.
Of the three AATAAA sequences within the CAB-2 coding region,
the one within MCP is preferentially used, accounting for 50% of
CAB-2 mRNA. This preference may be due to a GU – rich sequence
(UAUUUGAGUAUYUU) located 32 bp downstream of this AATAAA
that may act as a downstream regulatory element enhancing 30
end formation [9–11]. No such U – rich or GU – rich sequencesare located downstream of either of the two internal AATAAA se-
quences in DAF. In addition, the actual nucleotide sequences at
the site of 30 end cleavage can inﬂuence the efﬁciency of processing
[12] and that could be the case for the preferential use of the poly A
site within MCP versus the sites within DAF. Upstream enhancer
sequences also are known to modulate/enhance 30 end processing
and have been found in viral genes and in some human genes and
although a consensus has not emerged, they are often U-rich [9–
13]. Interestingly, all three regions within CAB-2 which contain
the AATAAA sequences also contain sequences resembling up-
stream enhancer elements. A GUUUUGUGU sequence is present
14 bp upstream of the AATAAA in MCP while UUAUGGAUAU and
UUUUCAU sequences lie 25 bp and 13 bp upstream of the AATAAA
sites in DAF SCR4 and STP regions, respectively. The presence of
GU-rich sequences both upstream and downstream of the poly site
in MCP also might be responsible for its preferential usage.
Use of the internal AATAAA sites for polyadenylation does not
appear to be unique to expression of the hybrid CAB-2 cDNA in
CHO-K1 cells since prematurely polyadenylated RNAs were ob-
served for MCP and DAF expressed in salivary gland and MCP ex-
pressed in PBL, placenta and the T-cell line, HSB2. While the use
of alternative poly(A) signals is known to be a molecular mecha-
nism of regulation in genes containing one or more sites in the
Fig. 5. Analysis of permanent transfectants obtained with the unmodiﬁed vs. modiﬁed CAB-2 vectors. (A) Titer (ng/ml) in 14 day extinct culture supernatants from 12 pools of
stable transfectants in 24-well plates. Each column represents the titer obtained from a single 24-well plate well seeded with 2  104 cells following transfection. The black
bar represents the average titer obtained for each group of 12 wells. The standard error of the mean is shown for the averages of the twelve titers from each group. (B) 30 RACE
in MCP using primer P6 and a poly(A) – speciﬁc reverse primer. Lane 1, a cell line generated using the unmodiﬁed CAB-2 plasmid. Lanes 2–4, three independent cell lines
generated using the modiﬁed plasmid. (C) 30 RACE in DAF using primer P7 and a poly(A) – speciﬁc reverse primer. Lane 1, a cell line generated using the unmodiﬁed CAB-2
plasmid, Lanes 2–3, two independent cell lines generated using the modiﬁed plasmid. (D) RT-PCR of cDNA from RNA isolated from CHO-K1 transfectants generated with the
modiﬁed plasmid, using Primer P1 and P3. M, DNA size marker, Lane 1, RNA from a CHO-K1 transfectant generated using the unmodiﬁed CAB-2 plasmid. Lanes 2–5, RNA from
4 independent CAB-2 transfectants obtained with the modiﬁed CAB-2 plasmid. Lane 6, RNA from untransfected CHO-K1 cells. Lane 7, plasmid DNA, Lane 8, negative (H2O)
control.
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human genes is rare [15]. Therefore, our demonstration of func-
tional polyadenylation signals within the coding exons of CAB-2
and in human tissues and cell lines expressing the native proteins
is unusual and their function (if any) is unknown.
Alternative splicing is known to be used for differential expres-
sion of genes in different tissues, during different phases of cell
growth and for alternative cellular localization of proteins [16].
Although mRNA heterogeneity of native MCP and DAF is well doc-
umented with several isoforms resulting from alternative splicing
[17–19], the biological signiﬁcance of these structural variations
is still under investigation. However, there is some evidence to
suggest that the various isoforms differ in their complement inhi-
bition proﬁles [18] as well as in their cellular localization [19].
While this propensity for heterogeneity suggested the possibility
of multiple mRNA forms, the speciﬁc non-productive RNA species
we observed, especially the abundant prematurely polyadenylated
RNA, have not been noted before. In addition, the alternative splic-
ing we observed with CAB-2 could not have been predicted as all
splice variants described to date arise from alternative splicing
downstream of the exons encoded in CAB-2. In addition, several
splice site recognition programs were unable to identify the sites
utilized in the CHO-K1 cell environment. It also should be noted
that the expression vector used in this study in which the cryptic
acceptor site was identiﬁed, has been used successfully for expres-sion of numerous other recombinant proteins with no evidence of
cryptic splicing.
In conclusion, this study demonstrates the importance of
screening recombinant gene sequences not only for mRNA struc-
ture effects but also for potential internal RNA processing signals,
such as premature polyadenylation signals and known canonical
splice sequences, that could adversely affect recombinant protein
expression. This type of screening is especially important when
creating fusion genes in which DNA sequences not naturally found
together are joined, bringing putative genetic elements promoting
alternative processing into close proximity. By identifying and
eliminating such internal RNA processing signals, recombinant
protein expression can be maximized.References
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